These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Chemotherapeutics-induced heart failure]. Paulides M; Wojnowski L Med Klin (Munich); 2007 Jul; 102(7):574-8. PubMed ID: 17634876 [TBL] [Abstract][Full Text] [Related]
8. [Cardiotoxicity of drugs used in the treatment of malignant neoplasms]. Ciubra-Niczewska E Pol Tyg Lek; 1983 Jan; 38(1):35-7. PubMed ID: 6866817 [No Abstract] [Full Text] [Related]
12. Doxorubicin cardiomyopathy: underlying cause of interferon-induced cardiac dysfunction? Geffen DB; Liel-Cohen N Isr Med Assoc J; 2007 Sep; 9(9):690; author reply 690-1. PubMed ID: 17939640 [No Abstract] [Full Text] [Related]
13. Evaluating the role of dexrazoxane as a cardioprotectant in cancer patients receiving anthracyclines. Pouillart P Cancer Treat Rev; 2004 Nov; 30(7):643-50. PubMed ID: 15531396 [TBL] [Abstract][Full Text] [Related]
14. Pathogenesis of cardiotoxicity induced by anthracyclines. Elliott P Semin Oncol; 2006 Jun; 33(3 Suppl 8):S2-7. PubMed ID: 16781283 [TBL] [Abstract][Full Text] [Related]
15. [Cardiac complications of various antineoplastic drugs]. Vernant JP; Francoual M Rev Prat; 1980 Feb; 30(7):321-4. PubMed ID: 7361041 [No Abstract] [Full Text] [Related]